Filter Results :

Your search for Infection returned 411 reports

Sort by


Respiratory Syncytial Virus Infections- Market Insights, Epidemiology and Market Forecast-2020

01 May 2016  |  Published by:  DelveInsight
The Respiratory Syncytial Virus Infections- Market Insights, Epidemiology and Market Forecast-2020 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and middle east countries ...

$ 4,950.00

Read More

Global Ultraviolet (UV) Disinfection Equipment Industry 2016 Market Research Report

28 Apr 2016  |  Published by:  9Dimen Research
2016 Global Ultraviolet (UV) Disinfection Equipment Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Ultraviolet (UV) Disinfection Equipment industry, focusing on the main regions (North America, Europe and Asia) and the main count...

$ 2,850.00

Read More

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016

20 Apr 2016  |  Published by:  GlobalData
Summary“Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016" provides an overview of Cytomegalovirus (HHV-5) Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Cytomegalovirus (HHV-5) Infections. Report includes an overvi...

$ 2,500.00

Read More

Neisseria meningitidis Infections - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Neisseria meningitidis Infections - Pipeline Review, H1 2016’, provides an overview of the Neisseria meningitidis Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neisseria meningitidis Infections,...

$ 2,000.00

Read More

Klebsiella pneumoniae Infections - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Klebsiella pneumoniae Infections - Pipeline Review, H1 2016’, provides an overview of the Klebsiella pneumoniae Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Klebsiella pneumoniae Infections, co...

$ 2,000.00

Read More

H1N1 Infection - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘H1N1 Infection - Pipeline Review, H1 2016’, provides an overview of the H1N1 Infection pipeline landscape. The report provides comprehensive information on the therapeutics under development for H1N1 Infection, complete with analysis by stage of development, drug tar...

$ 2,000.00

Read More

Acinetobacter Infections - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Acinetobacter Infections - Pipeline Review, H1 2016’, provides an overview of the Acinetobacter Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acinetobacter Infections, complete with analysis by ...

$ 2,000.00

Read More

Shigella Infections (Shigellosis) - Pipeline Review, H1 2016

20 Apr 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Shigella Infections (Shigellosis) - Pipeline Review, H1 2016’, provides an overview of the Shigella Infections (Shigellosis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Shigella Infections (Shigellosis),...

$ 2,000.00

Read More

Chlamydia Infections - Pipeline Review, H1 2016

13 Apr 2016  |  Published by:  Global Markets Direct
Summary‘Chlamydia Infections - Pipeline Review, H1 2016’, provides an overview of the Chlamydia Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chlamydia Infections, complete with analysis by stage of development, drug target, me...

$ 2,000.00

Read More

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2016

13 Apr 2016  |  Published by:  Global Markets Direct
Summary‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2016’, provides an overview of the Varicella Zoster (HHV-3) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Varicella Zoster (HHV-3) Infections, complete with anal...

$ 2,000.00

Read More

West Nile Virus Infections - Pipeline Review, H1 2016

13 Apr 2016  |  Published by:  Global Markets Direct
Summary‘West Nile Virus Infections - Pipeline Review, H1 2016’, provides an overview of the West Nile Virus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for West Nile Virus Infections, complete with analysis by stage of developmen...

$ 2,000.00

Read More

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2016

13 Apr 2016  |  Published by:  Global Markets Direct
Summary‘Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2016’, provides an overview of the Resistant Pseudomonas aeruginosa Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Resistant Pseudomonas aeruginosa Infect...

$ 2,000.00

Read More

Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics

05 Apr 2016  |  Published by:  GBI Research
SummaryViruses are infectious particles comprising a nucleic acid core – consisting of either DNA or RNA – and a protein coat known as a capsid. Infections attributable to viral pathogens are transmitted, directly or indirectly, from one person to another or from animal to human. Vir...

$ 4,995.00

Read More

Poxvirus Infections - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Poxvirus Infections - Pipeline Review, H1 2016’, provides an overview of the Poxvirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Poxvirus Infections, complete with analysis...

$ 2,000.00

Read More

Coronavirus Infection - Pipeline Review, H1 2016

22 Mar 2016  |  Published by:  Global Markets Direct
Summary‘Coronavirus Infection - Pipeline Review, H1 2016’, provides an overview of the Coronavirus Infection pipeline landscape. The report provides comprehensive information on the therapeutics under development for Coronavirus Infection, complete with analysis by stage of developme...

$ 2,000.00

Read More
Total 411 records.